Cargando…

Regulation of Macrophage Cell Surface GAPDH Alters LL-37 Internalization and Downstream Effects in the Cell

Mycobacterium tuberculosis (M.tb), the major causative agent of tuberculosis, has evolved mechanisms to evade host defenses and persist within host cells. Host-directed therapies against infected cells are emerging as an effective option. Cationic host defense peptide LL-37 is known to internalize i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dhiman, Asmita, Talukdar, Sharmila, Chaubey, Gaurav Kumar, Dilawari, Rahul, Modanwal, Radheshyam, Chaudhary, Surbhi, Patidar, Anil, Boradia, Vishant Mahendra, Kumbhar, Pradeep, Raje, Chaaya Iyengar, Raje, Manoj
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315065/ https://www.ncbi.nlm.nih.gov/pubmed/37080180 http://dx.doi.org/10.1159/000530083

Ejemplares similares

Exposure of a specific pleioform of multifunctional glyceraldehyde 3-phosphate dehydrogenase initiates CD14-dependent clearance of apoptotic cells
por: Chaudhary, Surbhi, et al.
Publicado: (2021)

Mycobacterium tuberculosis Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) Functions as a Receptor for Human Lactoferrin
por: Malhotra, Himanshu, et al.
Publicado: (2017)

Mycobacterium tuberculosis H37Ra: a surrogate for the expression of conserved, multimeric proteins of M.tb H37Rv
por: Boradia, Vishant Mahendra, et al.
Publicado: (2016)

Secreted multifunctional Glyceraldehyde-3-phosphate dehydrogenase sequesters lactoferrin and iron into cells via a non-canonical pathway
por: Chauhan, Anoop S., et al.
Publicado: (2015)

The Mycobacterium tuberculosis PE15/PPE20 complex transports calcium across the outer membrane
por: Boradia, Vishant, et al.
Publicado: (2022)

Generation of Monoclonal Antibodies Specific for Native LL37 and Citrullinated LL37 That Discriminate the Two LL37 Forms in the Skin and Circulation of Cutaneous/Systemic Lupus Erythematosus and Rheumatoid Arthritis Patients
por: Lande, Roberto, et al.
Publicado: (2020)

The Role of Cathelicidin LL-37 in Cancer Development
por: Piktel, Ewelina, et al.
Publicado: (2015)

Significance of LL-37 on Immunomodulation and Disease Outcome
por: Yang, Binbin, et al.
Publicado: (2020)

Regulation of LL-37 in Bone and Periodontium Regeneration
por: Chinipardaz, Zahra, et al.
Publicado: (2022)

Cathelicidin LL-37 in Health and Diseases of the Oral Cavity
por: Tokajuk, Joanna, et al.
Publicado: (2022)

Serum LL‐37 and inflammatory cytokines levels in psoriasis
por: Lao, Juanfeng, et al.
Publicado: (2023)

LL-37 Triggers Antimicrobial Activity in Human Platelets
por: Sánchez-Peña, Francisco Javier, et al.
Publicado: (2023)

CXCR2 specific endocytosis of immunomodulatory peptide LL-37 in human monocytes and formation of LL-37 positive large vesicles in differentiated monoosteophils
por: Zhang, Zhifang, et al.
Publicado: (2019)

Role of LL-37 in thrombotic complications in patients with COVID-19
por: Duan, Zilei, et al.
Publicado: (2022)

Impaired tolerance to the autoantigen LL-37 in acute coronary syndrome
por: Chernomordik, Fernando, et al.
Publicado: (2023)

LL-37 at the local site of streptococcal skin and soft-tissue infections
por: Thulin, Pontus, et al.
Publicado: (2007)

Evaluation of the Ability of LL-37 to Neutralise LPS In Vitro and Ex Vivo
por: Scott, Aaron, et al.
Publicado: (2011)

Vesicular LL-37 Contributes to Inflammation of the Lesional Skin of Palmoplantar Pustulosis
por: Murakami, Masamoto, et al.
Publicado: (2014)

Serum Levels of LL-37 and Inflammatory Cytokines in Plaque and Guttate Psoriasis
por: Hwang, Young Ji, et al.
Publicado: (2014)

LL-37 Induces Polymerization and Bundling of Actin and Affects Actin Structure
por: Sol, Asaf, et al.
Publicado: (2012)

Antimicrobial peptide LL-37 participates in the transcriptional regulation of melanoma cells
por: Muñoz, Mindy, et al.
Publicado: (2016)

Antimicrobial peptide LL-37 is bactericidal against Staphylococcus aureus biofilms
por: Kang, Jason, et al.
Publicado: (2019)

Pulmonary defense and the human cathelicidin hCAP-18/LL-37
por: Fahy, R. J., et al.
Publicado: (2005)

Synergistic Anti-Staphylococcal Activity Of Niosomal Recombinant Lysostaphin-LL-37
por: Sadeghi, Somayeh, et al.
Publicado: (2019)

Proteomic Adaptation of Streptococcus pneumoniae to the Human Antimicrobial Peptide LL-37
por: Mücke, Pierre-Alexander, et al.
Publicado: (2020)

Efficacy of Cathelicidin LL-37 in an MRSA Wound Infection Mouse Model
por: Simonetti, Oriana, et al.
Publicado: (2021)

The Potential of Human Peptide LL-37 as an Antimicrobial and Anti-Biofilm Agent
por: Ridyard, Kylen E., et al.
Publicado: (2021)

LL-37, a Multi-Faceted Amphipathic Peptide Involved in NETosis
por: Radic, Marko, et al.
Publicado: (2022)

Antimicrobial Peptide Loss, Except for LL-37, is not Characteristic of Atopic Dermatitis
por: SZABÓ, Lilla, et al.
Publicado: (2023)

LL-37 and Double-Stranded RNA Synergistically Upregulate Bronchial Epithelial TLR3 Involving Enhanced Import of Double-Stranded RNA and Downstream TLR3 Signaling
por: Bodahl, Sara, et al.
Publicado: (2022)

Cathelicidin LL-37: An Antimicrobial Peptide with a Role in Inflammatory Skin Disease
por: Reinholz, Markus, et al.
Publicado: (2012)

Spotlight on Human LL-37, an Immunomodulatory Peptide with Promising Cell-Penetrating Properties
por: Seil, Michèle, et al.
Publicado: (2010)

Transformation of Human Cathelicidin LL-37 into Selective, Stable, and Potent Antimicrobial Compounds
por: Wang, Guangshun, et al.
Publicado: (2014)

Upregulation of human β-defensin-3 and cathelicidin LL-37 in Kaposi’s sarcoma
por: Fathy, Hanan, et al.
Publicado: (2012)

Salivary concentration of the antimicrobial peptide LL-37 in patients with oral lichen planus
por: Davidopoulou, Sotiria, et al.
Publicado: (2014)

The Human Cathelicidin Antimicrobial Peptide LL-37 and Mimics are Potential Anticancer Drugs
por: Kuroda, Kengo, et al.
Publicado: (2015)

LL-37 boosts immunosuppressive function of placenta-derived mesenchymal stromal cells
por: Oliveira-Bravo, Martha, et al.
Publicado: (2016)

Human cathelicidin LL-37 enhance the antibiofilm effect of EGCG on Streptococcus mutans
por: Guo, Yi-jie, et al.
Publicado: (2016)

The impact of cathelicidin, the human antimicrobial peptide LL-37 in urinary tract infections
por: Babikir, Ibrahim H., et al.
Publicado: (2018)

Significance and Diagnostic Role of Antimicrobial Cathelicidins (LL-37) Peptides in Oral Health
por: Khurshid, Zohaib, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_9v9iva6jgelb1ih2amjtsva02r